Bal Pharma has an EPS of $1.639069. In 2022, the company made an earnings per share (EPS) of $3.785926. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | $1.64 | -56.71% |
2022 | $3.79 | 13.35% |
2021 | $3.34 | -138.75% |
2020 | -$8.62 | - |